Illustration of a hospital patient monitor displaying a rising stock chart while a doctor injects a syringe labeled $11.9M, symbolizing Oscar Health’s turnaround driven by CEO insider buying and tech-driven healthcare innovation.

CEO Bets $11.9M: Is Oscar Health (OSCR) About to Shock the Market? 🚀

Oscar Health (OSCR) is no longer just a flashy disruptor—it’s aiming for profitability. With CEO Mark Bertolini buying $11.9M in stock and revenue projected to hit $19B in 2026, this could be one of the most compelling turnaround plays in healthcare.

Read entire article

A cartoon-style health insurance card with Oscar Health’s logo, giant dollar signs, insider buy forms, and a stethoscope wrapped around a rocket ship — symbolizing fast-growing profits and smart money confidence.

Oscar Health: Its Own Is Shining and Insiders Knew!

Co-founder Joshua Kushner and Thrive Partners bought over $23 million of Oscar Health stock in late 2024. Since then? Record earnings, soaring revenue, and a stock still (surprisingly) within range. A healthy bet — or just a well-insured hunch?

Read entire article